A detailed history of Alpha Dna Investment Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 6,614 shares of JNJ stock, worth $962,866. This represents 0.41% of its overall portfolio holdings.

Number of Shares
6,614
Previous 13,383 50.58%
Holding current value
$962,866
Previous $1.96 Million 45.25%
% of portfolio
0.41%
Previous 0.78%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $984,754 - $1.13 Million
-6,769 Reduced 50.58%
6,614 $1.07 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $111,461 - $121,806
772 Added 6.12%
13,383 $1.96 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $977,109 - $1.02 Million
6,295 Added 99.67%
12,611 $1.99 Million
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $943,779 - $1.03 Million
-6,482 Reduced 50.65%
6,316 $989,000
Q3 2023

Nov 07, 2023

BUY
$155.75 - $174.48 $778 - $872
5 Added 0.04%
12,798 $1.99 Million
Q2 2023

Jul 31, 2023

BUY
$154.35 - $166.11 $1,543 - $1,661
10 Added 0.08%
12,793 $2.12 Million
Q1 2023

May 05, 2023

BUY
$151.05 - $180.26 $1.12 Million - $1.34 Million
7,424 Added 138.53%
12,783 $1.98 Million
Q4 2022

Jan 27, 2023

BUY
$160.2 - $179.79 $52,545 - $58,971
328 Added 6.52%
5,359 $0
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $625,153 - $695,640
3,875 Added 335.21%
5,031 $822,000
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $194,427 - $215,027
1,156 New
1,156 $205,000
Q2 2021

Aug 10, 2021

SELL
$159.48 - $171.07 $133,165 - $142,843
-835 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $11,174 - $12,445
73 Added 9.58%
835 $137,000
Q4 2020

Mar 24, 2021

SELL
$137.11 - $157.38 $2,193 - $2,518
-16 Reduced 2.06%
762 $119,000
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $106,671 - $122,441
778 New
778 $122,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.